StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report published on Saturday. The brokerage issued a hold rating on the biotechnology company’s ...
Thanks to this cutting-edge technology, stocks such as Nvidia and Palantir have experienced exponential increases in their stock prices. Nvidia's stock price began accelerating in 2023 amid its ...
In a note to clients on Sunday, Jefferies analyst Steven G. DeSanctis estimated that for 2025, the Sweet 16 would show an aggregate earnings increase of 21.5%, with a median increase of 15.8%. For the ...